Anzeige
Mehr »
Login
Dienstag, 30.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Basin Uranium: Es geht los! Der Uran-Superzyklus ist gestartet!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
25 Leser
Artikel bewerten:
(0)

Nutraceuticals: Dietary Supplements & Functional Foods & Beverages 2015-2022 - Despite Challenges and Concerns, Demand for Nutraceuticals Continue to Surge - Research and Markets

DUBLIN, Dec 15, 2016 /PRNewswire/ --

Research and Markets has announced the addition of the "Nutraceuticals - Global Strategic Business Report" report to their offering.

The report provides separate comprehensive analytics for the US, Canada, Japan Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.

This report analyzes the worldwide markets for Nutraceuticals in US$ by the following Product Groups/Segments:

  • Dietary Supplements (Vitamins, Minerals, Herbals, Non-Herbals, & Others)
  • Functional Foods & Beverages

The report profiles 284 companies including many key and niche players such as

  • Amway (USA)
  • Amyris, Inc. (USA)
  • Aneva Nutraceuticals Ltd. (UK)
  • AOR Canada (Canada)
  • Archer Daniels Midland Company (USA)
  • Arkopharma Laboratories S.A (France)
  • Bactolac Pharmaceuticals, Inc. (USA)
  • BASF SE (Germany)
  • BASF Human Nutrition (Germany)
  • Bayer Healthcare AG (Germany)
  • Bayer Consumer Care
  • Ceapro, Inc. (Canada)
  • CK Life Sciences Int'l (Holdings) Inc. (Hong Kong)
  • E.I.D Parry (India) Ltd. (India)
  • Parry Nutraceuticals (India)
  • Valensa International (USA)
  • Alimtec (Chile)
  • GlaxoSmithKline Plc. (UK)
  • Groupe Danone (France)
  • Infinitus (China) Company Ltd. (China)
  • Matsun Nutrition (USA)
  • MCM Klosterfrau Healthcare GmbH (Germany)
  • Mead Johnson Nutritionals, Inc. (USA)
  • Natrol Inc. (USA)
  • NBTY, Inc. (USA)
  • Nestlé SA (Switzerland)
  • Nestlé HealthCare Nutrition (Switzerland)
  • Nutraceutical Corporation (USA)
  • PepsiCo Inc. (USA)
  • Perrigo Company (USA)
  • Red Bull GmbH (Austria)
  • Royal DSM N.V. (The Netherlands)
  • The Coca-Cola Co. (USA)
  • Xiamen Kingdomway Group Company (China)

Key Topics Covered:

1. Industry Overview

2. Competition

3. Market Trends & Drivers

4. Nutraceuticals Innovations And Advancements

5. Key Issues Confronting The Market

6. Nutraceuticals: Regulatory Landscape

7. Product Overview

8. Product Launches

9. Recent Industry Activity

10. Focus On Select Global Players

11. Global Market Perspective

Total Companies Profiled: 284 (including Divisions/Subsidiaries 299)

  • The United States (203)
  • Canada (11)
  • Japan (6)
  • Europe (52)
  • - France (9)
  • - Germany (10)
  • - The United Kingdom (19)
  • - Italy (1)
  • - Rest of Europe (13)
  • Asia-Pacific (Excluding Japan) (27)

For more information about this report visit http://www.researchandmarkets.com/research/kqk654/nutraceuticals

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2016 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.